Kaken Pharmaceutical (4521.TSE) Q4 2025 Earnings

Nov 10Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-139
-51
36
124

Details

Expected EPS
N/A
Actual EPS
20
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨Kaken Pharmaceutical⁩ (⁦4521.TSE⁩) has reported earnings of ⁦20⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts